Century Therapeutics, Inc. (IPSC) Executive Compensation
Century Therapeutics, Inc. (IPSC) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IPSC
CIK: 1850119
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJason Frederick
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-02 | 2026-10-02 | FORM 8-K | 0001104659-26-113055 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | 4 Filing | 0001867305-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | 4 Filing | 0001867173-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 Filing | 0002001162-26-000018 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006940 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006939 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | 4 Filing | 0001452429-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-09 | 3 Filing | 0001452429-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | 4 Filing | 0002001162-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 Filing | 0001867305-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 Filing | 0001867173-26-000018 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | FORM 8-K | 0001104659-26-106312 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001959173-26-006793 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0002001162-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001104659-26-094533 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001104659-26-094523 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001867173-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-15 | FORM 8-K | 0001104659-26-074577 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 Filing | 0001867305-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 Filing | 0001867173-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0002001162-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0002039294-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001867172-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001543031-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0002127581-26-000006 | View SEC Doc Filr Page |